Skip to main navigation Skip to search Skip to main content

Efficacy and Safety of Deucravacitinib Compared with Placebo in Participants with Active SLE (POETYK SLE-2) (Protocol Number IM011247)

Upstate Medical University

Project: Research

Project Details

StatusActive
Effective start/end date08/22/24 → 08/21/26

Funding

  • Bristol Myers Squibb Company: $72,398.78